Abbott Boosts medical specialty Pipeline Zacks.com The deal is focused on the development and commercialization of BT-061 for the attention of rheumatoid arthritis (RA) and psoriasis . BT-061 is currently being evaluated in phase II studies for RA and disease of the skin . Moreover, the candidate's potential to be ... and more » Link To Article
No comments:
Post a Comment